NuCana News and Oncology Research & Biopharmaceutical Updates

1.05
0.00
0.00 %
Daily range
Weekly range
  • Viktoras Karapetjanc
  • 09.10.2026
NuCana stock breakout attempt at $1.25 resistance: Upside targets to watch
NuCana (NCNA) stock is trading at $1.18, gaining 4.89% since the previous close. The stock stands above its key short- and medium-term moving averages in today's ...
  • Dmytro Kharkov
  • 07.10.2026
NCNA rises as fragile gains persist amid volatility
NuCana (NCNA) stock is trading at $1.11, up 1.83% for the day. The price currently sits above its key short-term moving average while remaining below intermediate and ...
  • Yaroslav Dmytrenko
  • 06.10.2026
Why is NuCana stock up 7.5% today?
NuCana plc ADR (NCNA) jumped 7.55% in a short-covering rally triggered by oversold momentum signals as sellers began to exhaust downside pressure. The rebound looks limited, with NCNA still ...
  • Andrey Mastykin
  • 06.10.2026
NuCana stock forecast: Recovery attempt targets $1.22 resistance
NuCana (NCNA) stock is trading at $1.09 after a daily gain of 3.22%, with price action remaining below its key moving ...
  • Ivan Andriyenko
  • 05.10.2026
NuCana shares technical analysis: Support test at $0.89 in focus
NuCana (NCNA) stock is trading at $1.06 after a daily decline of 4.86%. The price remains below its key moving averages, indicating a clear short-term and long-term ...
  • Dmytro Kharkov
  • 02.10.2026
Will NuCana stock hold $1.10 support as oversold conditions limit further selling?
NuCana (NCNA) stock is trading at $1.12 after an intraday drop of 5.51%. It remains below its key moving averages, continuing to reflect strong downside momentum for the ...
  • Jainam Mehta
  • 01.10.2026
NuCana stock forecast: Short-term buying momentum fades, bearish signals increase
NuCana plc ADR (NCNA) stock is trading at $1.21, marking a daily move down of 11.03%. The price sits below its short- and medium-term moving averages, indicating current ...
  • Aleksandra Chaikina
  • 30.09.2026
NuCana stock rises nearly 12% as patent boost strengthens IP position
NuCana plc ADR (NCNA) surged 11.91% after the European Patent Office granted a key composition-of-matter patent covering its anti-cancer drug candidate, NUC-7738, reinforcing the company's ...
  • Oleg Tkachenko
  • 30.09.2026
NuCana stock resistance test: Breakout levels to watch
NuCana (NCNA) stock is trading at $1.31, up 6.5% on the day. The price is positioned above its key short- and medium-term moving ...
  • Andrey Mastykin
  • 29.09.2026
Why is NuCana stock down today? Sellers dominate with key support levels to watch
NuCana (NCNA) stock is trading at $1.26, reflecting a daily decline of 4.54%. The move leaves the price below its key moving averages after another session of selling ...
  • Ivan Andriyenko
  • 29.09.2026
NCNA slides over 4% as sellers keep control across multiple timeframes
NuCana plc ADR (NCNA) dropped 4.34% today as ongoing bearish momentum and persistent selling pressure remain dominant drivers. The move is supported by the stock trading below its 20-day, 50-day, ...
  • Viktoras Karapetjanc
  • 25.09.2026
Will NuCana stock hold $1.23 support as ongoing selloff deepens?
NuCana (NCNA) stock is trading at $1.28, down 2.74% for the day. The price sits below its key moving averages, pointing to ongoing pressure in both short- and long-term ...
  • Andrey Mastykin
  • 24.09.2026
Can NuCana stock regain momentum as upside attempts meet strong resistance?
NuCana (NCNA) stock is trading at $1.35 after climbing 3.05% during today's session. The price is positioned above its key moving averages, signaling positive short- and ...
  • Igor Krasulya
  • 23.09.2026
NuCana stock trades near $1.26 support amid persistent pullback pressure
NuCana (NCNA) stock is trading at $1.3 and has slipped 4.41% over the last session. The price remains below its key moving averages, reflecting ongoing downward ...
  • Viktoras Karapetjanc
  • 22.09.2026
NuCana stock holds steady as consolidation near $1.35 resistance continues
NuCana (NCNA) stock is trading at $1.33, posting a modest gain on the session. The price remains below its key moving averages, reflecting continued seller pressure in ...
  • Parshwa Turakhiya
  • 21.09.2026
NuCana stock tests $1.42 resistance as buyer support drives upward momentum
NuCana (NCNA) stock is trading at $1.38, up 4.54% on the day, with recent price action finishing near the session high. The stock sits above its key moving averages, ...
  • Mykhailo Ihnatenko
  • 18.09.2026
NuCana stock holds gains as upside is capped by overhead resistance
NuCana plc ADR (NCNA) edges higher today as mixed technical signals and deeply oversold readings help spur mild buying interest. The rebound appears limited, with the stock still trading beneath ...
  • Igor Krasulya
  • 17.09.2026
NuCana stock trades near $1.34 resistance as bullish momentum builds above short-term levels
NuCana (NCNA) stock is trading at $1.33, advancing 2.31% on the day. The price sits above its key short-term averages, but remains capped by important medium- to ...
  • Viktoras Karapetjanc
  • 09.09.2026
NuCana shares technical analysis: Challenge at $2.23 resistance
NuCana (NCNA) stock is trading at $1.45, up 3.57% for the session and finishing close to the daily high with moderate volatility. The price currently holds above its key ...
  • Viktoras Karapetjanc
  • 01.09.2026
NCNA drops as sellers dominate the short-term trend
NuCana (NCNA) stock is trading at $1.43, down 2.72% for the session. The stock remains below its key moving averages, reflecting sustained pressure within a volatile ...
  • Andrey Mastykin
  • 01.09.2026
NuCana shares fall over 3% as technical selling pressure drives downside gap
Technical selling pressure drove NuCana plc ADR (NCNA) down 3.36% today as the open triggered an early downside gap. Near-term resistance from moving averages limits any rebound attempts, keeping ...